Aberrant expression of CHFR in malignant peripheral nerve sheath tumors
Open Access
- 10 February 2006
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 19 (4), 524-532
- https://doi.org/10.1038/modpathol.3800548
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Chromosomal aberrations and microsatellite instability of malignant peripheral nerve sheath tumors: a study of 10 tumors from nine patientsCancer Genetics and Cytogenetics, 2006
- Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpointProceedings of the National Academy of Sciences, 2004
- Genomic structure of the human MAD2 gene and mutation analysis in human lung and breast cancersLung Cancer, 2001
- Rb and TP53 Pathway Alterations in Sporadic and NF1-Related Malignant Peripheral Nerve Sheath TumorsLaboratory Investigation, 2001
- Molecular analysis of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 in human lung cancersCancer Letters, 2001
- Chfr defines a mitotic stress checkpoint that delays entry into metaphaseNature, 2000
- Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study groupThe Journal of Pathology, 2000
- Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: SporadicVs. neurofibromatosis-type-1-associated malignant schwannomasInternational Journal of Cancer, 1999
- Mutations of mitotic checkpoint genes in human cancersNature, 1998
- When Checkpoints FailCell, 1997